Parallax Volatility Advisers, L.P. Spectrum Pharmaceuticals Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $74,620 - $149,240	-106,600 Reduced 91.42%	10,000 $8,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $247,800 - $372,300	15,000 Added 14.76%	116,600 $1.96 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $1.45 Million - $2.21 Million	101,600 New	101,600 $2.13 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.